ONC FY 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

FY 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$5.3B+40.2% YoY

Gross Profit

$4.7B87.5% margin

Operating Income

$447M8.4% margin

Net Income

$287M5.4% margin

EPS (Diluted)

$32.89

Cash Flow

Operating Cash Flow

$1.1B

Free Cash Flow

$942M

Stock-Based Comp.

$511M

Balance Sheet

Total Assets

$8.2B

Total Liabilities

$3.8B

Stockholders' Equity

$4.4B

Cash & Equivalents

$4.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.3B	$3.8B	+40.2%
Gross Profit	$4.7B	$3.2B	+45.3%
Operating Income	$447M	-$568M	+178.7%
Net Income	$287M	-$645M	+144.5%